GenKyoTex S.A. Provides Business Update For Q1 2017 Post author:Sam Post published:April 26, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Approves Genentech's Zelboraf, the First-Ever Drug to Treat Specific Rare Blood Disease November 6, 2017 Vexim Strengthens Its Intellectual Property Protection For The SpineJack In Asia: Two Patents Granted In China And Japan February 1, 2017 Amphastar Reports Financial Results For The Three Months And Fiscal Year Ended December 31, 2016 March 13, 2017
FDA Approves Genentech's Zelboraf, the First-Ever Drug to Treat Specific Rare Blood Disease November 6, 2017
Vexim Strengthens Its Intellectual Property Protection For The SpineJack In Asia: Two Patents Granted In China And Japan February 1, 2017
Amphastar Reports Financial Results For The Three Months And Fiscal Year Ended December 31, 2016 March 13, 2017